semaglutide compounding fda enforcement today Troubling Findings in Study of GLP-1 Compounders Compounded Semaglutide - HelloWellness

ET Saturday, June 6 DALLAS, JUNE 6, 2026 Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association , an open-access, peer-reviewed journal of the American Heart Association

Do not use Victoza if: you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Serious gastrointestinal complications require vigilant monitoring

All included participants provided written informed consent and were recruited prospectively

Improve elasticity and firmness while reducing sagging